Table 1 IFN-γ treatment upregulated the expression of cell surface molecules on PBMC-derived adherent cells
Cell surface markers | HLA class I | HLA class II | CD86 | |||
---|---|---|---|---|---|---|
IFN- γ treatment | (−) | (+) | (−) | (+) | (−) | (+) |
Donor 4 | 14.6a | 21.4 | 41.3 | 178 | 17.4 | 25.2 |
Donor 5 | 22.4 | 37.6 | 210 | 688 | 21.2 | 35.3 |